Identification of potential of new therapeutic approaches for JAK2 V617F mutant patients
Ontology highlight
ABSTRACT: n patients with PMF, excessive secretion of inflammatory cytokines results in fibrotic changes in bone marrow and diminishes the quality of life of the affected patients due to systemic symptoms long-term ruxolitinib therapy may reverse or markedly delay BM fibrosis progression in advanced MF suggests kavasincha 2018
INSTRUMENT(S): TripleTOF 6600
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Cell Culture
SUBMITTER: Bethany Geary
LAB HEAD: Bethany Geary
PROVIDER: PXD027250 | Pride | 2023-05-18
REPOSITORIES: Pride
ACCESS DATA